ACE and hepatocellular carcinoma: However, albeit significantly, the individual biomarkers AFP, DCP (PIVKA-II), and AFP-L3 poorly discriminated between HCC and cirrhosis, as measured by the AUCs for the established cutoffs between 0.65 and 0.69, and sensitivities between 35% and 47% (Figure 1E).